Simtuzumab

Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2) . Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC) [1].

Product Specifications

CAS Number

[1318075-13-6]

Product Name Alternative

AB 0024; GS 6624

UNSPSC

12352203

Target

Monoamine Oxidase

Type

Inhibitory Antibodies

Related Pathways

Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Cancer

Assay Protocol

https://www.medchemexpress.com/simtuzumab.html

Purity

99.0

Solubility

H2O

Smiles

[Simtuzumab]

Molecular Weight

(145.5 kDa)

References & Citations

[1]Wei Chen, et al. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis. Hepatology. 2020 Aug;72 (2) :729-741.